Dexcom Beats Q3 EPS by $0.06, Guides FY26 Revenue In Line
Dexcom reported Q3 earnings of $0.73 per share, excluding non-recurring items, $0.06 above the comparison figure. It guided FY26 revenue in line.
Story updates
08:20:22 PM UTC
SquawkNews
Dexcom Q3 revenue slightly beats; $1 bln share buyback announced